Acumen Pharmaceuticals, Inc.
52workers
SEC filingAnnounced
Acumen Pharmaceuticals, Inc. tells investors it plans to cut 52 positions
- Industry
- Biotech
- Filed with the SEC
- November 5, 2026
- Whose workers
- Scope not stated
- In the report for
- November 6, 2026
What happened
Acumen Pharmaceuticals, Inc. told the SEC it plans to reduce its workforce by 52 positions.
Sources
SEC EDGAR · SEC filing · Nov 5, 2026
In connection with these decisions, on November 1, 2026, the board of directors of the Company (the “Board”) approved certain steps to implement cash conservation measures, including a reduction of the Company’s workforce by 52 full-time employees, or approximately 90% of the Company’s current employee base (the “Restructuring”).
Read the source